Literature DB >> 19883330

Detection and diagnosis of Mycobacterium tuberculosis.

Faten A Al-Zamel1.   

Abstract

Tuberculosis continues to be a major health problem worldwide, affecting millions of people each year. Accurate and rapid diagnosis is key to controlling the disease, yet the traditional tests for TB produce results that are either inaccurate or take too long to be definitive. A fast and reliable diagnostic method that would differentiate between active and latent TB infection is also lacking. The current routine diagnostic tests for TB - chest x-ray, tissue culture, tuberculin skin test (TST) and acid-fast staining - all have their limitations. A chest x-ray alone is inconclusive; a tissue culture takes too long to produce a result; the TST lacks specificity and reliability; and acid-fast staining depends on a large number of bacteria in the sputum to give an accurate reading. Serological tests using different TB antigens to detect Mycobacterium tuberculosis infection are fast but lack the desired sensitivity. New methods have been developed, such as nucleic acid amplification technology which, although specific, can yield false-positive results. Immunologic tests (QuantiFERON and T-SPOT.TB), which measure the production of IFN-gamma by TB-specific T lymphocytes after encountering M. tuberculosis antigens, have certain advantages over the conventional tests, but they also have their disadvantages and unanswered questions. The need remains for a cost-effective, accurate and rapid method of diagnosing both active and latent TB infection.

Entities:  

Mesh:

Year:  2009        PMID: 19883330     DOI: 10.1586/eri.09.92

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  15 in total

Review 1.  Toward a unified biosignature for tuberculosis.

Authors:  Jeroen Maertzdorf; Stefan H E Kaufmann; January Weiner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-23       Impact factor: 6.915

2.  Application of molecular, microbiological, and immunological tests for the diagnosis of bone and joint tuberculosis.

Authors:  Yinghua Tang; Lianli Yin; Shifu Tang; Hongyu Zhang; Jihui Lan
Journal:  J Clin Lab Anal       Date:  2017-05-22       Impact factor: 2.352

3.  The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay.

Authors:  M Barnard; N C Gey van Pittius; P D van Helden; M Bosman; G Coetzee; R M Warren
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

Review 4.  Advances and challenges in biosensor-based diagnosis of infectious diseases.

Authors:  Mandy L Y Sin; Kathleen E Mach; Pak Kin Wong; Joseph C Liao
Journal:  Expert Rev Mol Diagn       Date:  2014-02-13       Impact factor: 5.225

5.  Cloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens.

Authors:  Shima Mahmoudi; Setareh Mamishi; Mona Ghazi; Reihaneh Hosseinpour Sadeghi; Babak Pourakbari
Journal:  Iran J Microbiol       Date:  2013-12

6.  Paper-based tuberculosis diagnostic devices with colorimetric gold nanoparticles.

Authors:  Tsung-Ting Tsai; Shu-Wei Shen; Chao-Min Cheng; Chien-Fu Chen
Journal:  Sci Technol Adv Mater       Date:  2013-08-06       Impact factor: 8.090

7.  Clinical value of a whole blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection during antitubercular treatment.

Authors:  Haifeng Wang; Zhenyun Li; Qunmei Zhang; Guangjian Lu; Qingjiang Wang; Ligong Zhang; Chenguang Zhang
Journal:  Exp Ther Med       Date:  2013-05-21       Impact factor: 2.447

8.  IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis.

Authors:  Xiaoyan Feng; Xiqin Yang; Bingshui Xiu; Shuang Qie; Zhenhua Dai; Kun Chen; Ping Zhao; Li Zhang; Russell A Nicholson; Guohua Wang; Xiaoguo Song; Heqiu Zhang
Journal:  BMC Infect Dis       Date:  2014-06-17       Impact factor: 3.090

9.  Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting.

Authors:  M M Z Matabane; F Ismail; K A Strydom; O Onwuegbuna; S V Omar; N Ismail
Journal:  BMC Infect Dis       Date:  2015-11-09       Impact factor: 3.090

10.  High sensitivity and specificity of a 5-analyte protein and microRNA biosignature for identification of active tuberculosis.

Authors:  Jessica L Pedersen; Simone E Barry; Nilesh J Bokil; Magda Ellis; YuRong Yang; Guangyu Guan; Xiaolin Wang; Alen Faiz; Warwick J Britton; Bernadette M Saunders
Journal:  Clin Transl Immunology       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.